Literature DB >> 22379622

Glucocorticosteroid-resistant pemphigoid gestationis: successful treatment with adjuvant immunoadsorption.

Lilia Westermann1, Rainer Hügel, Markus Meier, Michael Weichenthal, Detlef Zillikens, Regine Gläser, Enno Schmidt.   

Abstract

A 40-year old prima para presented with multiple urticaria-like plaques and severe pruritus 2 weeks prior to giving birth by cesarean section. Three days after birth, the disease flared up and tense blisters appeared on hands, lower arms and feet. Based on the clinical presentation, direct immunofluorescence microscopy, complement binding test and detection of high levels of circulating anti-BP180 antibodies, the diagnosis of pemphigoid gestationis was established. Despite treatment with class IV topical corticosteroid and prednisolone p.o. up to 60 mg/day, both skin lesions and severe pruritus progressed accompanied by increasing anti-BP180 antibody serum levels. In order to continue breast feeding, the prednisolone dose could not be further increased and 10 immunoadsorptions over 4 weeks were performed. During this period, skin lesions cleared rapidly, pruritus subsided and BP180-specific serum autoantibodies decreased by 99.5% allowing the reduction of prednisolone to 7.5 mg/day. We conclude that immunoadsorption is an effective and safe adjuvant therapeutic option for severe pemphigoid gestationis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22379622     DOI: 10.1111/j.1346-8138.2011.01376.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  6 in total

Review 1.  [Immunoadsorption in dermatology].

Authors:  Franziska Hübner; Michael Kasperkiewicz; Detlef Zillikens; Enno Schmidt
Journal:  Hautarzt       Date:  2019-01       Impact factor: 0.751

Review 2.  Targeted Therapies for Autoimmune Bullous Diseases: Current Status.

Authors:  Kyle T Amber; Roberto Maglie; Farzan Solimani; Rüdiger Eming; Michael Hertl
Journal:  Drugs       Date:  2018-10       Impact factor: 9.546

3.  [Tryptophan immunoadsorption for multiple sclerosis and neuromyelitis optica: therapy option for acute relapses during pregnancy and breastfeeding].

Authors:  F Hoffmann; A Kraft; F Heigl; E Mauch; J Koehler; L Harms; T Kümpfel; W Köhler; R Klingel; C Fassbender; S Schimrigk
Journal:  Nervenarzt       Date:  2015-02       Impact factor: 1.214

Review 4.  Pemphigoid gestationis: current perspectives.

Authors:  Christine Sävervall; Freja Lærke Sand; Simon Francis Thomsen
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-11-08

5.  Shifting Focus in the Therapeutics of Immunobullous Disease.

Authors:  Abhishek De; Asad Ansari; Nidhi Sharma; Aarti Sarda
Journal:  Indian J Dermatol       Date:  2017 May-Jun       Impact factor: 1.494

Review 6.  Gestational pemphigoid.

Authors:  Laura Huilaja; Kaarin Mäkikallio; Kaisa Tasanen
Journal:  Orphanet J Rare Dis       Date:  2014-09-02       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.